Latanoprost/Timolol Kent Pharma Uk

Timolol maleate and latanoprost, the active ingredient in Latanoprost/Timolol Kent Pharma Uk, is a beta blocker and prostaglandin analog presented as an ophthalmic solution for ocular use. It treats open-angle glaucoma and ocular hypertension by lowering intra‑ocular pressure. GNH USA supplies Latanoprost/Timolol Kent Pharma Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost/Timolol is indicated for conditions affecting intra‑ocular pressure within the glaucoma and ocular hypertension disease family. - Open‑angle glaucoma: reduces intra‑ocular pressure to prevent optic‑nerve damage and visual field loss. - Ocular hypertension: lowers pressure to reduce the risk of progression to glaucoma. - Secondary open‑angle glaucoma: helps control pressure when caused by other ocular conditions.

Common Side Effects: - Eye irritation or burning sensation after instillation. - Conjunctival hyperemia (redness of the eye). - Transient blurred vision. - Darkening of the iris or peri‑ocular skin. - Increased eyelash growth.

Serious or Rare Side Effects: - Severe allergic reaction with swelling, itching, or rash. - Uveitis or iritis presenting as eye pain and photophobia. - Persistent ocular pain or vision loss. - Systemic beta‑blocker effects such as bradycardia, hypotension, or bronchospasm. - Acute angle‑closure glaucoma precipitated by pupil dilation.

Before using Latanoprost/Timolol, consider the following precautions: - Cardiovascular assessment: monitor heart rate and blood pressure in patients with cardiac disease. - Respiratory caution: avoid in patients with asthma or chronic obstructive pulmonary disease. - Diabetes monitoring: beta‑blockade may mask hypoglycaemia symptoms. - Contact lens use: advise removal of lenses before and for several hours after instillation. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk. - Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost/Timolol may interact with other medicines as follows:

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers: additive bradycardia or hypotension. - Other ocular beta‑blocker drops: excessive intra‑ocular pressure reduction. - Additional prostaglandin analog eye drops: increased risk of ocular irritation.

Moderate Interactions (Monitor Closely): - Inhaled beta‑agonists (e.g., albuterol): may reduce bronchodilator efficacy. - Calcium channel blockers: possible additive cardiovascular effects. - Anticholinergic eye drops: may alter pupil response. - NSAID eye preparations: potential for increased ocular inflammation.